Discover oncology
Comparative efficacy of Palbociclib and Everolimus with aromatase inhibitors in second line treatment of HR and HER2 negative metastatic breast cancer.
Nadia Najafizade, Shadi Zarei, Mohammadreza Elhaie, Mahnaz Roayaei
Published: 202510.1007/s12672-025-04330-0
No abstract available for this study.